Similar articles

• Monoclonal antibodies specific immunotherapy of gastrointestinal tumors.

  Douillard JY, Lehur PA, Vignoud J, Blottière H, Maurel C, Thedrez P, Kremer M, Le Mevel B. Douillard JY, et al. Hybridoma. 1986 Jul;5 Suppl 1:S139-49. Hybridoma. 1986. PMID: 3527945 Clinical Trial.
• Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.

  Byers VS, Rodvien R, Grant K, Durrant LG, Hudson KH, Baldwin RW, Scannon PJ. Byers VS, et al. Cancer Res. 1989 Nov 1;49(21):6153-60. Cancer Res. 1989. PMID: 2790828
• Radioimmunoguided surgery in primary colon cancer.

  Nieroda CA, Mojzisik C, Sardi A, Ferrara PJ, Hinkle G, Thurston MO, Martin EW Jr. Nieroda CA, et al. Cancer Detect Prev. 1990;14(6):651-6. Cancer Detect Prev. 1990. PMID: 2257564
• Clinical status of monoclonal antibodies in the treatment of colorectal carcinoma.

  Mellstedt H, Frodin JE, Masucci G. Mellstedt H, et al. Oncology (Williston Park). 1989 Dec;3(12):25-32; discussion 37-9, 42. Oncology (Williston Park). 1989. PMID: 2701408 Review.
• [Recent management of metastatic colorectal cancer].

  Kato T, Hirai T, Yasui K. Kato T, et al. Gan To Kagaku Ryoho. 1998 Oct;25(12):1865-72. Gan To Kagaku Ryoho. 1998. PMID: 9797809 Review. Japanese.